摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

n-Butoxy methyl formate | 273223-83-9

中文名称
——
中文别名
——
英文名称
n-Butoxy methyl formate
英文别名
formic acid butoxymethyl ester;Ameisensaeure-butoxymethylester;Butoxymethyl formate
n-Butoxy methyl formate化学式
CAS
273223-83-9
化学式
C6H12O3
mdl
——
分子量
132.159
InChiKey
MEEGGHGBOIGPMT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    154 °C
  • 密度:
    0.960±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    9
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:f7a2e247265a169c3c16f736d7f3efca
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • HALOALKYLSULFONANILIDE DERIVATIVE
    申请人:Kai Masanori
    公开号:US20120029187A1
    公开(公告)日:2012-02-02
    Novel herbicides are provided. A haloalkylsulfonanilide derivative represented by the formula (1) or an agrochemically acceptable salt thereof: the formula (1): wherein Z is —C(R 9 )(R 10 )— or —N(R 11 )—, A is an oxygen atom, a sulfur atom or —N(R 12 )—, W is an oxygen atom or a sulfur atom, m is an integer of from 0 to 3, n is an integer of from 0 to 3, m+n is from 1 to 3, R 1 is halo C 1 -C 6 alkyl, R 2 is a hydrogen atom, C 1 -C 6 alkyl or the like, each of R 3 and R 4 is independently a hydrogen atom, C 1 -C 6 alkyl or the like, each of R 5 , R 6 , R 7 , R 8 , R 9 and R 10 is independently a hydrogen atom, a halogen, C 1 -C 6 alkyl or the like, each of R 11 and R 12 is a hydrogen atom, C 1 -C 6 alkyl, halo C 1 -C 6 alkyl or the like, and X is independently a hydrogen atom, a halogen, C 1 -C 6 alkyl, or the like.
    提供新型除草剂。 一种由式(1)表示的卤烷基磺酰苯胺生物或其农药可接受的盐: 式(1): 其中Z为—C(R9)(R10)—或—N(R11)—,A为氧原子、原子或—N(R12)—,W为氧原子或原子,m为0至3的整数,n为0至3的整数,m+n为1至3,R1为卤代C1-C6烷基,R2为氢原子、C1-C6烷基或类似物,R3和R4中的每一个独立地为氢原子、C1-C6烷基或类似物,R5、R6、R7、R8、R9和R10中的每一个独立地为氢原子、卤素、C1-C6烷基或类似物,R11和R12中的每一个为氢原子、C1-C6烷基、卤代C1-C6烷基或类似物,X独立地为氢原子、卤素、C1-C6烷基或类似物。
  • NOVEL CONDENSED IMIDAZOLE DERIVATIVE
    申请人:Dainippon Sumitomo Pharma Co., Ltd.
    公开号:EP1690863A1
    公开(公告)日:2006-08-16
    Disclosed is a compound represented by the formula (1) below which has a high DPP-IV inhibitory activity and is improved in safety, toxicity and the like. Also disclosed is a prodrug of such a compound and pharmaceutically acceptable salts of them. (In the formula, R1 represents a hydrogen atom, an optionally substituted alkyl group or the like; R2 and R3 independently represent a hydrogen atom, an optionally substituted alkyl group or the like; R4 and R5 independently represent a hydrogen atom, an optionally substituted alkyl group or the like: R6 represents a hydrogen atom, an optionally substituted aryl group or the like; and -Y-NH2, represents a group represented by the following formula (A): (wherein m is 0, 1 or 2; and R7 may not exist or one or two R7 may exist and independently represent an optionally substituted alkyl group or the like) or the like.]
    揭示了一种化合物,其化学式如下(1),具有较高的DPP-IV抑制活性,并在安全性、毒性等方面得到改善。还披露了这种化合物的前药和其药用可接受的盐。(在该式中,R1代表氢原子、可选择取代的烷基或类似物;R2和R3独立代表氢原子、可选择取代的烷基或类似物;R4和R5独立代表氢原子、可选择取代的烷基或类似物;R6代表氢原子、可选择取代的芳基或类似物;-Y-NH2代表由以下式(A)表示的基团:(其中m为0、1或2;R7可能不存在,或一个或两个R7可以存在且独立代表可选择取代的烷基或类似物)或类似物。)
  • ISOXAZOLIN-5-ONE DERIVATIVE AND HERBICIDE CONTAINING SAME AS ACTIVE INGREDIENT
    申请人:HOKKO CHEMICAL INDUSTRY CO., LTD.
    公开号:US20200267985A1
    公开(公告)日:2020-08-27
    An isoxazolin-5-one derivative represented by the following (1): wherein R 1 represents a C1-C6 haloalkyl group, and R 2 to R 4 and X each represents a certain substituent or the like; and n represents an integer of 1 to 4, wherein X's may be different from each other when n represents an integer of 2 to 4, and an herbicide containing the isoxazolin-5-one derivative as an active ingredient are provided.
    提供一种由以下式(1)表示的异氧代异噁唑啉-5-酮衍生物:其中R1代表C1-C6卤代烷基,R2到R4和X各代表一定的取代基或类似物;n代表1到4的整数,当n代表2到4的整数时,X可能互不相同,并提供一种以异氧代异噁唑啉-5-酮衍生物为活性成分的除草剂
  • ISOXAZOLIN-5-ONE DERIVATIVES AND HERBICIDES CONTAINING THE SAME AS ACTIVE INGREDIENTS
    申请人:HOKKO CHEMICAL INDUSTRY CO., LTD.
    公开号:US20210309619A1
    公开(公告)日:2021-10-07
    An isoxazolin-5-one derivative represented by formula (1) below: wherein R 1 represents a C1-C6 haloalkyl group, Q represents a C3-C8 cycloalkyl group substituted with a C1-C6 alkoxy group, each of R 2 , R 3 and X represents a certain substituent or the like, and n represents an integer of 1 to 4, wherein X's may be different from each other when n represents an integer of 2 to 4, and a herbicide containing the isoxazolin-5-one derivative as an active ingredient are provided.
    以下是公式(1)所代表的异氧唑啉-5-酮衍生物的中文翻译:其中R1代表一个C1-C6卤代烷基基团,Q代表一个带有一个C1-C6烷氧基团的C3-C8环烷基基团,R2、R3和X中的每一个代表某种取代基或类似物,n代表1到4之间的整数,当n代表2到4之间的整数时,X可能彼此不同,提供了一种含有异氧唑啉-5-酮衍生物作为活性成分的除草剂
  • PHENYLIMIDAZOLE DERIVATIVE, AND THERAPEUTIC MEDICINE OR PREVENTIVE MEDICINE FOR INFLAMMATORY DISEASE, ETC.
    申请人:NIPPON SODA CO., LTD.
    公开号:US20160145242A1
    公开(公告)日:2016-05-26
    A medicinal active ingredient is provided which is useful for the treatment or prevention of inflammatory diseases, diseases caused by lipid oxidation, retinochoroidal disorders. A phenylimidazole derivative represented by Formula (IB) or a salt thereof is provided. A therapeutic medicine or preventive medicine is provided for inflammatory diseases, diseases caused by lipid oxidation, or retinochoroidal disorders, the medicine including at least one selected from the phenylimidazole derivative, a salt thereof, and metabolites thereof as an active ingredient. In Formula (IB), R 1a represents an alkyl group etc., R 2 represents an amino group etc., R 3 represents a halogen atom, an alkyl group etc., R 4 represents a cyano group etc., R 5 represents an alkyl group etc., and R 6 represents an alkyl group etc.
    提供了一种药用活性成分,可用于治疗或预防炎症性疾病、脂质氧化引起的疾病、视网膜脉络膜疾病。提供了一种由式(IB)所代表的苯基咪唑生物或其盐,该衍生物可用作治疗或预防炎症性疾病、脂质氧化引起的疾病或视网膜脉络膜疾病的治疗药物或预防药物,该药物包括至少选自苯基咪唑生物、其盐和其代谢物中的一种作为活性成分。在式(IB)中,R1代表烷基等,R2代表基等,R3代表卤素原子、烷基等,R4代表基等,R5代表烷基等,R6代表烷基等。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸